Xi'an Dapeng Biological Technology Co., Ltd, founded in July 2000 with a registered capital of 60 million RMB yuan, is a hi-tech enterprise acknowledged by Shaanxi Provincial Government which is chiefly engaged in the research, development and production of stachyose and its series of products.
          Major shareholders of Dapeng Company are 6 enterprise juridical persons of Xi'an Pengyu Industrial Development Company, Xi'an Rongfeng Technological Development Co., Ltd, Shaanxi Electric Shangde Industry and Trade Co., Ltd, China Hi-tech Investment Group, China General Import & Export Company of Engineering and Agricultural Machine, etc.

         Among the 139 employees of Dapeng are 5 doctors and masters, 25 high and intermediate title holders. Over 80% of its staff are college graduates. Besides, there are a group of efficient and capable high-level and intermediate managers.
      Xi'an Dapeng Biological Technology Co., Ltd undertakes some state-level priority projects such as torch program hi-tech industrialization demonstration and transformation funds of agro-technological achievements and has attained the world advanced level in the field of stachyose production.
         Its products are superior in quality and outstanding in effects. They have been identified by the research institute of space food as the diet for the astronaut on China 's Shenzhou No.5 Spaceship.
         Its managing mechanism is modern and complete; its organization is sound and simple; its regulation are comprehensive but concise; its internal control system is all-sided and effective.
         Xi'an Dapeng Biological Technology Co., Ltd has forged a completed marketing system and its marking network covers foods, health products and drugs in China and other countries.

          Dapeng has cultivated an outstanding and unique enterprise culture; the spirit of magnanimity, transcendence, gratitude and win-for-all is the consensus of Dapeng people; devotion, cooperation, commitment and civilization are the guidelines for their behavior.